MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-JK-19-0000144
Anphar Organics Private Limited. - pharma in Jammu, Jammu And Kashmir, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹36.7 Cr
▲ 17% YoY
Net profit · FY 2025
₹7.03 Cr
Net margin 19.1%
EBITDA · FY 2025
₹10.79 Cr
EBITDA margin 29.4%
Authorised capital
₹8.5 Cr
Registered with MCA
Paid-up capital
₹3.13 Cr
Issued & subscribed
Open charges
₹12.4 Cr
Satisfied ₹15.83 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
107
Provident fund records
About Anphar Organics Private Limited.
Data last updated:
Anphar Organics Private Limited. is a private limited company based in Jammu, Jammu And Kashmir, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 November 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U24231JK1994PTC001409. Its GSTIN is 01AAECA5483G1ZZ (Jammu and Kashmir).
The company has an authorised share capital of ₹8.5 Cr and a paid-up capital of ₹3.13 Cr. It is led by directors including Shailender Gupta (Whole-Time Director) and Sivasamy Manohar.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SIDCO Epip Kartholi Bari Brahmana, Jammu, Jammu and Kashmir, India – 181133.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.7 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹7.03 Cr (net margin 19.1%) and EBITDA of ₹10.79 Cr (EBITDA margin 29.4%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 6% over five years.
The company has about 107 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹12.4 Cr and satisfied charges of ₹15.83 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it. The company has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹7.99 Cr; the latest was in January 2021. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Mednext Biotech Limited with revenue of ₹36.86 Cr. The company has 10 MSME Form 1 returns on record for the period ending Dec 2018, listing 11 overdue payments to 11 micro and small suppliers.
Anphar Organics Private Limited. is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-JK-19-0000144). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website madraspharma.com.
Company details
CIN U24231JK1994PTC001409
Registration Number 001409
Incorporation Date 29 November 1994
ROC Jammu
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-JK-19-0000144
Recognitions & Rankings of Anphar Organics Private Limited
Contact details
Anphar Organics Private Limited.'s registered office is in Jammu, Jammu And Kashmir. Its website is madraspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSIDCO Epip Kartholi Bari Brahmana, Jammu, Jammu and Kashmir, India – 181133
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Anphar Organics Private Limited., buy the company report.
Comprehensive company report
Anphar Organics Private Limited. - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Anphar Organics Private Limited is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Anphar Organics Private Limited., buy the company report.
Financials of Anphar Organics Private Limited.
FY 2025 filings availableAnphar Organics Private Limited. reported revenue of ₹36.7 Cr (up 17% YoY) for FY 2025.
Revenue · FY 2025
₹36.7 Cr ▲ 17%
Net profit · FY 2025
₹7.03 Cr margin 19.1%
EBITDA · FY 2025
₹10.79 Cr margin 29.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▼ 6%
5 years · compounded
▼ 6%
EBITDA CAGR growth
1 year
▲ 610%
3 years · compounded
▲ 45%
5 years · compounded
▲ 2%
Revenue rose 17% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA rose 610% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.79 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.03 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 29.4% | ||||
| Net Profit Margin | 19.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anphar Organics Private Limited., buy the company report.
Board of directors of Anphar Organics Private Limited.
Anphar Organics Private Limited has 7 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sivasamy Manohar Also directs: Pulmocare Lifesciences India Private Limited, Maral Health Care Private Limited, Madras Pharmaceuticals Private Limited and 3 more | Director | 07 Aug 2014 | 12 Years 3 Months | Current |
| Alagappan Also directs: Maral Health Care Private Limited, Madras Pharmaceuticals Private Limited, Sunberg Life Sciences Private Limited and 2 more | Director | 07 Aug 2014 | 12 Years 3 Months | Current |
| Krishnamurthy Balakumar | Director | 07 Aug 2014 | 12 Years 3 Months | Current |
| Shailender Gupta | Whole-Time Director | 10 Mar 2015 | 11 Years 7 Months | Current |
| Sulaiman Abdulhai Mohammed Also directs: Pulmocare Lifesciences India Private Limited, Maral Health Care Private Limited, Madras Pharmaceuticals Private Limited and 5 more | Director | 02 Mar 2012 | 14 Years 8 Months | Current |
| Nagappan Kannappan Also directs: Maral Health Care Private Limited, Madras Pharmaceuticals Private Limited, Sunberg Life Sciences Private Limited and 2 more | Director | 07 Aug 2014 | 12 Years 3 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
Anphar Organics Private Limited. is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mednext Biotech Limited | ₹36.86 Cr (FY 2025) | -32.0% | Udaipur, Rajasthan, India | |||
| Bharat Explosives Limited | ₹36.81 Cr (FY 2025) | -13.0% | Uttar Pradesh, India | |||
| Shukra Pharmaceuticals Limited | ₹36.79 Cr (FY 2025) | -52.0% | Ahmedabad, Gujarat, India | |||
| Gitanjali Chemicals Private Limited | ₹36.72 Cr (FY 2024) | -21.0% | Mumbai, Maharashtra, India | |||
| Anphar Organics Private Limited.this company | ₹36.7 Cr (FY 2025) | ₹7.03 Cr | 19.1% | 17.0% | 107 | Jammu, Jammu And Kashmir, India |
| Balaji Formulations Private Limited | ₹36.59 Cr (FY 2023) | -10.0% | Hyderabad, Telangana, India | |||
| Stanex Drugs and Chemicals Private Limited | ₹36.54 Cr (FY 2024) | -47.0% | Hyderabad, Telangana, India | |||
| Vivimed Labs (Alathur) Private Limited | ₹36.32 Cr (FY 2016) | 29.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Anphar Organics Private Limited., buy the company report.
Auditor
Anphar Organics Private Limited. is audited by Arora Vohra & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Arora Vohra & Co. | FY 2024 | 9487N |
Shareholding
The shareholding of Anphar Organics Private Limited. is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Anphar Organics Private Limited., buy the company report.
Charges & borrowings
Open charges
₹12.4 Cr
Satisfied charges
₹15.83 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Sep 2024 | 100988629 | Hdfc Bank Limited | ₹3.3 Cr | Open | |
| 26 Aug 2020 | 100372495 | Hdfc Bank Limited | ₹1.6 Cr | Open | |
| 27 Aug 2013 | 10447583 | Hdfc Bank Limited | ₹7.5 Cr | Open | |
| 14 Jun 2016 | 100037703 | Hdfc Bank Limited | ₹9 Cr | Satisfied | |
| 10 Jun 2014 | 10518665 | Hdfc Bank Limited | ₹1.5 Cr | Satisfied |
To see the full charge records of Anphar Organics Private Limited., buy the company report.
Total charge records: 11 View all charges
Deals & funding
Anphar Organics Private Limited. has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹7.99 Cr; the latest was in January 2021.
Total deals
8
Funding rounds
4
Secondary share transfers
4
Disclosed funding
₹7.99 Cr
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Secondary share transfer | Undisclosed | Seller: Softgel Healthcare Private Limited |
| Dec 2012 | Secondary share transfer | Undisclosed | Buyer: Accent-Pharma Seller: G.C. Chemie Pharmie Limited |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: Accent-Pharma, 3 individuals Seller: Anphar Laboratories Private Limited , Viva Biotech Private Limited, 2 individuals |
| Jan 2012 | Funding round | ₹1.33 Cr | Investors: Anphar Laboratories Private Limited , Viva Biotech Private Limited, 2 individuals |
| Mar 2010 | Funding round | ₹57 Lakh | Investors: Anphar Laboratories Private Limited , Viva Biotech Private Limited |
To see the full deal history of Anphar Organics Private Limited., buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Anphar Organics Private Limited. has 3 court cases on record: 2 filed by Anphar Organics Private Limited, 1 filed against it. All cases are disposed.
Total cases
3
Filed by the company
2
Filed against the company
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (1807-Ordinary Civil Matters : Others) | Filed against the company by Union of India Through Ministry of Health and Family Welfare Government of India Ministry of Health and Family Welfare Government of India, Nirman Bhavan , District: New Delhi ,New Delhi , Delhi and 27 others | Disposed |
| High Court of Delhi | Writ petition | Filed by the company against Union of India | Disposed |
To see the full case history of Anphar Organics Private Limited., buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Anphar Organics Private Limited. has 10 MSME Form 1 returns on record for the period ending Dec 2018, listing 11 overdue payments to 11 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 11)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Halcyon Labs Private Limited | |||
| Central Drug House | |||
| Baddi Foils Private Limited | |||
| Fortuner Packaging | |||
| Nugenic Pharma Private Limited |
To see the full MSME payment records of Anphar Organics Private Limited., buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Anphar Organics Private Limited. has a workforce of 107 employees on its EPFO records as of Feb 27, 2025, across 1 active EPFO establishment.
Employee count
107
Active EPFO establishments
1
Employee growth
3.88%
GST
Anphar Organics Private Limited has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 01AAECA5483G1ZZ | Jammu and Kashmir | Active | 08 Jul 2017 |
To see the full GST registrations and return filing status of Anphar Organics Private Limited., buy the company report.
Recent activity
Anphar Organics Private Limited. has 18 board changes on record since 2012: 7 appointments and 11 cessations. The latest: Himanshu Bansal ceased to be Whole-Time Director on 20 Jun 2015.
AGM
Anphar Organics Private Limited. last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Anphar Organics Private Limited. has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jammu.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 3.30 Cr with Charge ID 100988629 was registered on 23 Sep 2024.
Charges
A charge registered on 14 Jun 2016 via Charge ID 100037703 with Hdfc Bank Limited was fully satisfied on 03 Sep 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.60 Cr with Charge ID 100372495 was registered on 26 Aug 2020.
Charges
A charge with Hdfc Bank Limited of Rs. 7.50 Cr registered on 27 Aug 2013 with Charge ID 10447583 was modified on 29 Jun 2018.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 9.00 Cr with Charge ID 100037703 was registered on 14 Jun 2016.
Ceased
Himanshu Bansal ceased to be Whole-Time Director.
Appointed
Shailender Gupta was appointed as Whole-Time Director.
Ceased
Shailender Gupta ceased to be Additional Director.
Charges
A charge registered on 10 Jun 2014 via Charge ID 10518665 with Hdfc Bank Limited was fully satisfied on 11 Nov 2014.
Ceased
Alagappan ceased to be Additional Director.
30 earlier events are in the company report.
Frequently asked questions
Anphar Organics Private Limited is an active private limited company based in Jammu, Jammu And Kashmir, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 November 1994 (32+ years old) and is registered under CIN U24231JK1994PTC001409.
Anphar Organics Private Limited has 7 current directors:
- Shailender Gupta - Whole-Time Director
- Sivasamy Manohar - Director
- Alagappan - Director
- Krishnamurthy Balakumar - Director
- Sulaiman Abdulhai Mohammed - Director
- Nagappan Kannappan - Director
- Ogra Selvanathan Kumaran - Director
The latest financial statements of Anphar Organics Private Limited on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Anphar Organics Private Limited is 01AAECA5483G1ZZ, registered in Jammu and Kashmir.
The CIN (Corporate Identification Number) of Anphar Organics Private Limited is U24231JK1994PTC001409. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anphar Organics Private Limited has 3 court cases on record: 2 filed by the company and 1 filed against it. Most are in the high courts.
Anphar Organics Private Limited was incorporated on 29 November 1994, making it 32+ years old. It is registered with the Registrar of Companies, Jammu.
Anphar Organics Private Limited has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹7.99 Cr; the latest was in January 2021.
The peers of Anphar Organics Private Limited by revenue are Mednext Biotech Limited, Bharat Explosives Limited, Shukra Pharmaceuticals Limited, Gitanjali Chemicals Private Limited, Balaji Formulations Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Himanshu Bansal ceased to be Whole-Time Director on 20 Jun 2015. Shailender Gupta was appointed as Whole-Time Director on 10 Mar 2015. Shailender Gupta ceased to be Additional Director on 10 Mar 2015. Anphar Organics Private Limited has 18 board changes on record in total.
Yes, Anphar Organics Private Limited is registered as a medium enterprise under Udyam registration (number: UDYAM-JK-19-0000144).
Anphar Organics Private Limited has 10 MSME Form 1 returns on record for the period ending Dec 2018, listing 11 overdue payments to 11 micro and small suppliers. The latest return was filed on 04 Jun 2019.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages